Astellas is committed to providing timely and accurate information about our business, science and products. This section offers global resources for investors, journalists and media professionals. News and resources from our local affiliates can be viewed in the Local news section. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Tokyo, Japan, August 10, 2012 – Astellas Pharma Inc. (“Astellas”, headquarters: Tokyo; President and CEO: Yoshihiko Hatanaka) and AstraZeneca K.K. (“AstraZeneca”, headquarters: Osaka;...
Tokyo, August 8, 2012 - Astellas Pharma Inc. (“Astellas Pharma”; Tokyo:4503; President and CEO: Yoshihiko Hatanaka) today announced that it submitted an application for market authorization...
Tokyo, August 6, 2012 - Astellas Pharma Inc. (“Astellas”; Tokyo:4503; President and CEO: Yoshihiko Hatanaka) announced that it decided to close Urogenix, Inc. (“Urogenix”, Durham, NC,...
Read more about Astellas to Close Urogenix, North Carolina-based Urology Research Facility
Tokyo, July 30, 2012 – Astellas Pharma Inc. (“Astellas,” Tokyo: 4503) today announced that it will hold its annual “Changing Tomorrow Day” (CT Day), an event in which Astellas Group...
Tokyo, Japan, July 30, 2012 – Tokyo Institute of Technology (“Tokyo-Tech”) and Astellas Pharma Inc. (Tokyo:4503,“Astellas”) announced on July 30 that they have signed a joint research...
Follow us
